2023-07-10 10:00:00 ET
With market capitalizations ranging from $3.6 billion to $7.2 billion, these four mid-cap stocks offer multi-bagger potential. Doximity (NYSE: DOCS) and Progyny (NASDAQ: PGNY) are home to first-mover advantages -- giving them a head start over their competition. Meanwhile, Medpace (NASDAQ: MEDP) and InMode (NASDAQ: INMD) look to beat the market with their best-in-class profitability. All are driven by decades-long megatrends working in their favor.
Let's explore why these healthcare businesses are prime selections to buy in July and hold forever.
Home to over 80% of doctors and over 50% of nurse practitioners and physician assistants in the U.S., Doximity's physician cloud has quickly drawn the attention of the largest companies in its industry. Counting the top 20 hospitals and top 20 pharmaceutical companies as customers, Doximity's platform has rapidly become a staple within the healthcare industry.
For further details see:
4 Top Stocks to Buy in July and Hold Forever